×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61

12 Marijuana Stocks to Buy Now

Posted on Sunday, June 26th, 2022 by MarketBeat Staff
There are now more than 50 publicly-traded companies operating in the cannabis industry. Most of these companies aren't directly growing and selling marijuana themselves, but they do stand to benefit greatly as more states legalize the sale and possession of marijuana. Some of these marijuana stocks are media companies. Others are privately studying the medical uses of marijuana. Yet others are providing tools and software for marijuana growers. As more cannabis companies file IPOs and enter the stock market, it will become increasingly difficult for investors to identify which marijuana stocks will truly benefit from the cannabis boom.

Our subscribers have begun digging through these companies, checking out their financials, business models and long-term growth prospects. They know that some "marijuana stocks" are just empty shell companies that deserve to be penny stocks, but they also recognize there are some legitimate and growing companies that truly stand to benefit from the green rush. As a group, they have added 10 different cannabis stocks to their watchlists and are actively investing in them. More than 1,400 MarketBeat subscribers are now following our top-trending cannabis company.

This slide show lists the 12 pot stocks that MarketBeat subscribers are have added to their watchlists and are actively monitoring.

#1 - Canopy Growth (TSE:WEED)

MarketBeat Followers
2,818
Market Cap
C$1.97 billion
Consensus Rating
Hold
Rating Score
1.8
Ratings Breakdown
3 Buy Ratings, 5 Hold Ratings, 6 Sell Ratings.
Consensus Price Target
C$8.63 (76.7% Upside)

Canopy Growth logoCanopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
6/13/2022Jefferies Financial GroupLower Price TargetC$8.80 ➝ C$5.50
6/8/2022BMO Capital MarketsDowngradeSellC$2.50
5/30/2022CowenLower Price TargetBuyC$6.50
5/30/2022CIBCLower Price TargetUnderperformC$6.50 ➝ C$5.00
5/30/2022CowenLower Price TargetC$12.50 ➝ C$6.50
5/27/2022CfraReiterated RatingHoldC$10.00
5/24/2022Canaccord Genuity GroupLower Price TargetC$10.00 ➝ C$6.00
5/20/2022Eight CapitalLower Price TargetSellC$7.00 ➝ C$5.50
5/20/2022Alliance Global PartnersDowngradeHoldC$11.00 ➝ C$8.00
5/19/2022CIBCLower Price TargetUnderperformC$9.00 ➝ C$6.50



#2 - Innovative Industrial Properties (NYSE:IIPR)

MarketBeat Followers
1,766
Market Cap
$3.34 billion
Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$239.00 (100.3% Upside)

Innovative Industrial Properties logoInnovative Industrial Properties, Inc is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Innovative Industrial Properties, Inc has elected to be taxed as a real estate investment trust, commencing with the year ended December 31, 2017.
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
6/2/2022JMP SecuritiesLower Price TargetBuy$300.00 ➝ $190.00
5/9/2022Craig HallumUpgradeHold ➝ Buy$175.00
4/1/2022BTIG ResearchReiterated RatingBuy$290.00
3/25/2022BTIG ResearchReiterated RatingBuy$290.00
1/14/2022Piper SandlerLower Price Target$290.00 ➝ $285.00
11/4/2021JMP SecuritiesBoost Price TargetOutperform$260.00 ➝ $300.00
9/1/2021BTIG ResearchBoost Price TargetPositive ➝ Buy$245.00 ➝ $290.00
8/9/2021Craig HallumBoost Price TargetHold$175.00 ➝ $240.00
8/6/2021Roth CapitalBoost Price TargetBuy$215.00 ➝ $245.00
7/2/2021Wolfe ResearchInitiated CoverageOutperform$249.00



#3 - Unrivaled Brands (OTCMKTS:TRTC)

MarketBeat Followers
1,554
Market Cap
$20.82 million
Consensus Rating
N/A
Rating Score
NaN
Ratings Breakdown
0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
N/A

Unrivaled Brands logoTerra Tech Corp. cultivates, produces, and retails medical and adult use cannabis products. The company also operates medical marijuana retail and adult use dispensaries, cultivation, and production facilities in California and Nevada under the Blüm name in California and Nevada. Terra Tech Corp. was founded in 2010 and is based in Santa Ana, California.
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails



#4 - 22nd Century Group (NASDAQ:XXII)

MarketBeat Followers
1,353
Market Cap
$398.18 million
Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$6.13 (153.1% Upside)

22nd Century Group logo22nd Century Group, Inc, an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies.Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
6/15/2022Craig HallumInitiated CoverageBuy$5.00
3/8/2022Roth CapitalInitiated CoverageBuy$6.00
1/6/2022Dawson JamesBoost Price TargetBuy ➝ Buy$7.00 ➝ $8.50
7/23/2021CowenInitiated CoverageOutperform$5.00
8/4/2020Bradley WoodsReiterated RatingBuy
7/21/2019Chardan CapitalSet Price TargetBuy$12.00



#5 - Cannabis Science (OTCMKTS:CBIS)

MarketBeat Followers
1,345
Consensus Rating
N/A
Rating Score
NaN
Ratings Breakdown
0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
N/A

Cannabis Science logoCannabis Science, Inc, together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance.Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails



#6 - OrganiGram (TSE:OGI)

MarketBeat Followers
1,182
Market Cap
C$429.76 million
Consensus Rating
Hold
Rating Score
2.4
Ratings Breakdown
4 Buy Ratings, 2 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
C$3.06 (123.1% Upside)

OrganiGram logoOrganigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co, Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates.Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/14/2022Raymond JamesSet Price TargetOverweightC$3.00
4/13/2022Jefferies Financial GroupLower Price TargetC$3.44 ➝ C$3.34
4/13/2022ATB CapitalUpgradeSector Perform ➝ OutperformC$3.00
4/12/2022Atb Cap MarketsUpgradeSector Perform ➝ Outperform
3/15/2022Raymond JamesLower Price TargetOutperformC$5.00 ➝ C$3.00
1/12/2022ATB CapitalBoost Price TargetSector PerformC$2.65 ➝ C$3.00
1/12/2022Canaccord Genuity GroupUpgradeHold ➝ Speculative BuyC$3.00 ➝ C$3.25
1/10/2022Raymond JamesReiterated RatingOutperformC$5.00
1/7/2022Alliance Global PartnersLower Price TargetNeutral ➝ UnderperformC$4.00 ➝ C$2.25
12/22/2021Raymond JamesReiterated RatingOutperformC$5.00



#7 - KushCo (OTCMKTS:KSHB)

MarketBeat Followers
1,162
Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
N/A

KushCo logoKushCo Holdings, Inc provides ancillary products and services to the legal cannabis and CBD industries. The firm through its subsidiaries and brands provides product quality, exceptional customer service, compliance knowledge and a local presence in serving diverse customer base. The company was founded by Dallas Imbimbo, John Kovacevich, Nicholas Kovacevich, and Jeffrey Meng on December 15, 2010 and is headquartered in Cypress, CA.
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/16/2021Roth CapitalReiterated RatingBuy
6/16/2021Roth CapitalLower Price TargetBuy$2.25 ➝ $2.00
1/12/2021Roth CapitalBoost Price TargetBuy$2.00 ➝ $2.25
7/9/2020Alliance Global PartnersReiterated RatingBuy
7/9/2020Northland SecuritiesReiterated RatingHold
3/16/2020Northland SecuritiesDowngradeOutperform ➝ Market Perform
1/9/2020BenchmarkLower Price TargetBuy$5.00 ➝ $4.00
11/27/2019Jefferies Financial GroupInitiated CoverageBuy$3.50
11/8/2019Northland SecuritiesReiterated RatingBuy$6.00
9/25/2019Compass PointBoost Price TargetBuy$5.00 ➝ $8.00



#8 - GrowGeneration (NASDAQ:GRWG)

MarketBeat Followers
1,065
Market Cap
$253.91 million
Consensus Rating
Hold
Rating Score
2.4
Ratings Breakdown
3 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$16.31 (290.3% Upside)

GrowGeneration logoGrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. It engages in the marketing and distribution of nutrients, growing media, advanced indoor and greenhouse lighting, environmental control systems, vertical benching, and accessories for hydroponic gardening, as well as other indoor and outdoor growing products.Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/12/2022OppenheimerLower Price Target$50.00 ➝ $15.00
5/11/2022Wells FargoLower Price Target$8.00 ➝ $4.00
5/11/2022Alliance Global PartnersLower Price Target$14.00 ➝ $7.00
3/3/2022Roth CapitalDowngradeBuy ➝ Neutral$20.00 ➝ $8.00
3/2/2022Alliance Global PartnersLower Price Target$20.00 ➝ $14.00
3/1/2022Wells FargoLower Price TargetEqual Weight$11.00 ➝ $9.00
1/14/2022Stifel NicolausLower Price Target$24.00 ➝ $10.00
1/14/2022Craig HallumDowngradeBuy ➝ Hold$30.00 ➝ $12.50
1/13/2022Alliance Global PartnersLower Price Target$35.00 ➝ $20.00
1/13/2022Lake Street CapitalLower Price Target$44.00 ➝ $19.00



#9 - Medical Marijuana (OTCMKTS:MJNA)

MarketBeat Followers
1,057
Consensus Rating
N/A
Rating Score
NaN
Ratings Breakdown
0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
N/A

Medical Marijuana logoMedical Marijuana, Inc, an investment holding company, operates in the cannabinoid-based nutraceutical industry. It focuses on the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil; treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products; and nonpsychoactive cannabidiol products.Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails



#10 - Marijuana Company of America (OTCMKTS:MCOA)

MarketBeat Followers
849
Consensus Rating
N/A
Rating Score
NaN
Ratings Breakdown
0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
N/A

Marijuana Company of America logoMarijuana Company of America, Inc, together with its subsidiaries, develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand name in the United States. The company offers hempSMART products comprising hempSMART Brain, a patented and formulated personal care consumer product for brain wellness; hempSMART Pain capsules for temporary relief of minor discomfort with physical activity; hempSMART Pain Cream to reduce minor discomfort and promote muscle relaxation; hempSMART Drops, a hemp CBD oil tincture drops; hempSMART Pet Drops for cats and dogs; hempSMART Face, a facial moisturizer; and hempSMART drink mix, an industrial hemp based powderized CBD drink through its web site and affiliate marketing programs.Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails



#11 - Cannabis Sativa (OTCMKTS:CBDS)

MarketBeat Followers
581
Consensus Rating
N/A
Rating Score
NaN
Ratings Breakdown
0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
N/A

Cannabis Sativa logoCannabis Sativa, Inc, through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology.Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails



#12 - United Cannabis (OTCMKTS:CNAB)

MarketBeat Followers
512
Market Cap
$1.55 million
Consensus Rating
N/A
Rating Score
NaN
Ratings Breakdown
0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
N/A

United Cannabis logoUnited Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical marijuana and marijuana infused products in the United States. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy.Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails



 




MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.